P207news.today207Wed 28 Oct20:33
NEWS.TODAY
BUSINESS 7/9
GSK shares fall as vaccine sales disappoint investors
GSK shares fell up to 7% on Wednesday after the pharmaceutical company reported a 2% drop in vaccine sales to £2.6bn in the third quarter.
GSK shares fell sharply on Wednesday after the British pharmaceutical giant reported weaker vaccine sales, despite posting better-than-expected overall profits. Vaccine sales fell 2% to £2.6bn in the three months to September, with its shingles jab Shingrix down 5% and RSV vaccine Arexvy down 24%. Shares dropped as much as 7% in morning trading, making GSK one of the biggest fallers on the FTSE 100, though losses were later pared back.
From 4 outlets:
Summary written by AI from these reports. See news.today/ai
OL: —